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Abstract
Purpose This study investigated the psychometric yield of extension of the EQ-5D-5L with a cognitive domain (EQ-5D+C) 
in a mixed cohort of trauma patients with repeated data.
Methods A stratified sample of patients that presented at the emergency department filled out a follow-up survey 6 and 
12 months after trauma. The surveys included the EQ-5D-5L+C, EQ-VAS, and the impact of events scale-revised (IES-R), a 
validated post-traumatic stress disorder (PTSD) self-assessment scale. Generally, results of the EQ-5D and EQ-5D+C were 
compared. Psychometrics included the following: distributional features (ceiling/floor effects), discriminatory performance, 
convergent validity with the EQ-VAS as reference, and responsiveness to change. Psychometric properties were compared 
between predefined subgroups based on conditions with cognitive impact (Traumatic Brain Injury (TBI)/PTSD).
Results In total, 1799 trauma patients responded 6 and 12 months after trauma, including 107 respondents with PTSD, and 
273 with TBI. Six months post-trauma, ceiling of the EQ-5D (26.3%) was reduced with 2.2% with the additional cognitive 
domain. Using EQ-VAS as reference, convergent validity increased slightly with the addition of the cognitive domain: cor-
relation increasing from 0.651 to 0.664. Cognitive level was found to slightly improve over time in TBI (delta: 0.04) and 
PTSD patients (delta: 0.05), while (almost) no change was found in patients without TBI and PTSD.
Conclusion Adding a cognitive domain to the EQ-5D-5L slightly improved measurement properties and better captured 
change in health status for trauma patients with TBI and PTSD. Inclusion of the cognitive domain in the EQ-5D-5L when 
measuring in populations with cognitive problems should be considered.
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Background
Measuring health-related quality of life (HRQL) is an impor-
tant aspect of research in trauma patients [1]. HRQL can be 
measured with either a generic or a disease-specific meas-
urement instrument [2]. One of the most widely used pref-
erence-based generic health status instruments is the EQ-5D 
[3]. The EQ-5D is a measurement instrument based on 
self-assessment that consists of five domains: mobility, self-
care, usual activities, pain/discomfort and anxiety/depres-
sion [4]. Each domain contains one item that informs on 
the degree of problems. The major advantage of the EQ-5D 
compared to other generic instruments is its conciseness, and 
therefore low burden to complete [5, 6]. Ordinal response 
scales to the EQ-5D have either 3 levels (EQ-5D-3L) or 5 
levels (EQ-5D-5L) [3].
The EQ-5D-3L is known to show a ceiling distribution, 
which implies that the ability to measure small changes in 
the upper part of the health scale is limited [7]. Stated other-
wise: the instrument does not artificially increase distances 
in the upper part of the scale for the sake of discrimina-
tion. The three-level version and five-level version have 
been compared in previous studies to determine whether 
a 5-level response scale adds value to the measurement 
instrument. Janssen et al. [8], for example, reported that 
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most measurement properties improved with the EQ-5D-5L. 
Only few studies compared head-to-head the responsiveness 
(sensitivity to change) of the three- versus five-level version 
[9–12]. The results of these studies were contradictory, as 
responsiveness did not improve in the five-level version in 
two of the studies [9; 10], while it did improve in the study 
by Buchholz et al. and Janssen et al. [11, 12].
Apart from extending the EQ-5D response categories 
from three to five to improve sensitivity, previous studies 
have also suggested that additional domains to the EQ-
5D-3L, so-called ‘bolt-ons’, may improve the measurement 
properties in both general and specific populations [13–16]. 
One of the proposed bolt-ons, which is often already added 
to the EQ-5D, is a cognitive domain (EQ-5D-3L+C). Vari-
ous studies showed that measurement properties improved 
slightly if the cognitive domain is added to the EQ-5D-3L 
when comparing EQ-5D and EQ-5D+C cross-sectionally 
[17, 18]. One of these studies assessed the added value of 
the cognitive domain in a sample of trauma patients in the 
Brabant region of the Netherlands who were admitted to the 
hospital due to a traumatic brain injury (TBI) [17]. How-
ever, measurement properties and responsiveness of the EQ-
5D-5L extended with cognition in a general trauma popula-
tion, including patients with cognitive conditions (such as 
TBI, but also post-traumatic stress disorder (PTSD)), has 
not been studied using the current methodology developed 
for 3L/5L comparisons. Therefore, in this study, we investi-
gated the added value of the cognitive domain using supple-
mentary psychometric analysis and more recently collected 
repeated follow-up data from trauma patients.
The aim of this study was to investigate the convergent 
validity, descriptive dependency and responsiveness of the 
EQ-5D-5L and the EQ-5D-5L+C in a comprehensive sam-
ple of trauma patients.
Methods
Research population
This study was conducted with data from the ‘Letsel infor-
matie systeem’ (LIS) (Dutch injury patient surveillance sys-
tem). LIS is an ongoing data collection in fourteen (out of 
approximately 90) hospitals in the Netherlands [19]. The 
fourteen hospitals are a representative sample of hospitals in 
the Netherlands and consist of academic and non-academic 
and rural and urban hospitals. The LIS hospitals register 
information on age, sex, circumstances of trauma, cause of 
trauma, in-hospital health care consumption, such as length 
of hospital stay and nature of trauma of each patient that 
visits the emergency department due to a trauma or poison-
ing [20]. After treatment of trauma, the patient was admit-
ted to the hospital or discharged to the home environment 
or institution. The data used in this study were limited to 
the data collected in 2017. A stratified sample of patients 
received questionnaires 6  months and 12  months after 
trauma, with exclusion criterion for participation < 15 years 
old. The first questionnaire contained an informed consent 
form. Approval by the Medical Ethics Review Committee 
(METC) was not required according to the METC of the 
Academic Medical Center of the University of Amsterdam. 
The questionnaires contained questions on education level, 
comorbidity and HRQL. HRQL was measured with the EQ-
5D-5L with cognitive domain and with the EQ-VAS.
HRQL data
The EQ-5D-5L is a measurement instrument that consists 
of five domains with each five response levels. The five 
domains are mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression. Cognition was added as 
a sixth domain to the five existing domains. The response 
options of the 5-level version are no problems, slight prob-
lems, moderate problems, severe problems, and extreme 
problems/unable to. Responses to the five EQ-5D and six 
EQ-5D+C domains can be combined in so-called health 
profiles, which define the severity level, where 1 means no 
problems and 5 means extreme problems or unable to per-
form, e.g. ‘21421′ for EQ-5D and ‘132512′ for EQ-5D+C. 
An unweighted summary score (level sum score) can be cal-
culated from the responses to the EQ-5D, ranging from 5 to 
25 for the EQ-5D and 6 to 30 for the EQ-5D with cognition. 
To enable comparison between the two level sum scores, 
scores on the EQ-5D+C were recoded to the same scale 
as scores on the EQ-5D by multiplying the level sum score 
with 5/6. In addition to the six domains of the EQ-5D, the 
EQ-VAS is also part of the EQ-5D. The EQ-VAS requires 
respondents to rate their health on a scale from 0 to 100, 
where 0 represents the worst imaginable health state, and 
100 represents best imaginable health. Furthermore, the 
impact of events scale-revised (IES-R), which informs on 
PTSD-related complaints, was included in the questionnaire. 
The IES-R is a self-report questionnaire that consists of 22 
items, which measure intrusive re-experiences of the trauma, 
avoidance of trauma-related stimuli and hyper arousal symp-
toms [21]. By combining the 22 items the total IES-score, 
ranging from 0 through 88, can be calculated. The cut-off 
score was set at 33, as advised by Creamer, Bell and Failla 
[22], with scores below 33 representing no PTSD, and scores 
equal to or higher than 33 representing PTSD. Data were 
imputed for respondents with one or two missing items on 
the IES-R using simple imputation, based on responses to 
other items of the IES-R. In addition, the first questionnaire 
included 19 items regarding the presence of one or more 
chronic diseases prior to trauma to assess comorbidity. 
Comorbidity is defined as the self-reported presence of any 
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co-existing medical diseases or disease processes additional 
to the trauma that the trauma patients sustained.
Data analysis
Data analyses were performed in SPSS version 25. Respond-
ents were included in the analyses if an answer was pro-
vided for the EQ-5D+C and the EQ-VAS both 6 months 
and 12 months after trauma. The presence of traumatic brain 
injury (TBI) was determined based on the trauma registra-
tion in the LIS, and comorbidity was determined based on 
information from the follow-up questionnaire at 6 months. 
Comorbidity was divided in categories: no comorbidity; one 
comorbidity; two or more comorbidities. Furthermore, pres-
ence of PTSD was determined based on responses to the 
IES-R, which was included in the questionnaire at 6 months. 
Frequencies of socio-demographic characteristics were com-
pared between responders and non-responders using Chi-
square tests and Mann–Whitney U tests. A distributional 
effect in terms of ceiling was determined by defining the 
proportion of perfect health profiles (11111 for EQ-5D 
and 111111 for EQ-5D+C) among all observed profiles. A 
higher proportion of perfect health profiles indicates more 
ceiling.
Informativity, expressed as classification power of EQ-5D 
and EQ-5D+C was determined with the Shannon Index (H′) 
and Shannon Evenness Index (J′) [23]. Information on the 
ability to measure diversity in a population can be derived 
from these two indices [24]. To calculate the Shannon Index, 
the formula: H′ = − ∑ci=1 pi 2log pi was used, where  pi rep-
resents the proportion of people with one health profile, and 
C represents the total number of possible health profiles. A 
higher value of H′ indicates that more information is cap-
tured by the measurement instrument. For EQ-5D, the total 
number of possible health profiles was 3125 (5 × 5 × 5 × 5 × 
5), whereas for EQ-5D+C there were 15,625 possible health 
profiles. Next, the Shannon Evenness Index was calculated, 
based on the Shannon Index: J′ = H′/H′max, with H′max rep-
resenting 2logC (total number of possible health profiles). 
A higher value on the Shannon Evenness Index represents 
the capture of more information by the extra domain, and 
therefore increases the distinction between patients [8]. As 
the assessment of H′ using a sample of the total population 
will lead to an underestimation according to Pielou [25], 
adjusted values were calculated for H′ and J′ to control for 
this. Adjustment magnitude was set at (C − 1)/2N. Classifi-
cation efficiency was determined for subgroups of respond-
ents with TBI, PTSD and neither TBI nor PTSD, both for 
6-month and 12-month measurement.
Furthermore, convergent validity of the EQ-5D-5L and 
the EQ-5D-5L+C was determined by the strength of associa-
tion between the EQ-5D-5L with and without cognition with 
the EQ-VAS. First, the level sum score was calculated for 
both EQ-5D and EQ-5D+C as the sum of all domains (e.g. 
health profile 33333 had a level sum score of 15). The level 
sum score ranges from 5 to 25 for EQ-5D and 6 to 30 for 
EQ-5D+C, with a higher score representing poorer health. 
Subsequently, after confirmation that the assumptions were 
met, Spearman’s rank correlation coefficients between 
EQ-5D (all versions) and EQ-VAS were determined for the 
6-month and 12-month assessments.
Additionally, explanatory power of EQ-5D and EQ-
5D+C were determined using multivariable linear regression 
analyses, as the assumptions of linear regression were met, 
with EQ-VAS as dependent variable. Independent variables 
consisted of dummy variables for the levels ‘slight problems, 
moderate problems, severe problems, and extreme problems/
unable to’ for all EQ-5D domains including cognition for the 
EQ-5D+C, with ‘no problems’ as the reference category. All 
combinations of 5 out of the 6 EQ-5D+C domains were ana-
lysed separately for TBI/PTSD respondents and for respond-
ents with neither TBI nor PTSD.
Discriminatory power
Mean level sum score was determined for both EQ-5D and 
EQ-5D+C at 6-month measurement. Scores were compared 
between subgroups of TBI/PTSD versus no TBI/PTSD, and 
no comorbidity versus one comorbidity versus two or more 
comorbidities, respectively. The level sum scores of EQ-5D 
and EQ-5D+C were compared within each subgroup using 
paired t-tests. Furthermore, level sum scores were compared 
between subgroups using one-way ANOVA.
Responsiveness
Mean difference between reported EQ-5D and EQ-5D+C 
responses collected at 6 months and 12 months post-trauma 
were analysed per domain to gain insight into the average 
change per domain over time. The mean difference was 
calculated per domain by subtracting the 6-month score 
from the 12-month score: D12−D6
N
, where D12 represents the 
score on the domain at 12 months, D6 the score on the same 
domain at the 6-month assessment, and N the total number 
of respondents. This resulted in a score between − 4 and 4.
Furthermore, EQ-5D and EQ-5D+C health profiles were 
compared at 6 months and 12 months using the Paretian 
classification of Health Change [26]. Based on the difference 
between the two measurement moments, respondents were 
classified as follows: no change; no problems; improved 
health; worsened health; non-categorisable (mixed change). 
Difference in classification between EQ-5D and EQ-5D+C 
was compared for subgroups of the population, based on the 
presence of TBI and PTSD.
To quantify change over time per domain, the probabil-
ity of superiority was calculated by dividing the number 
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of respondents with positive change (in terms of health 
improvement over time) by the total sample size. Half of 
the respondents that were categorised as ‘no change’ were 
added to the number of respondents with positive change to 
account for ties. Both the Paretian classification of Health 
Change and the probability of superiority can be interpreted 
as measures of responsiveness to change.
Hypotheses
The following hypotheses were formulated:
– The ceiling effect is smaller with the EQ-5D+C com-
pared to the EQ-5D;
– The convergent validity of the EQ-5D+C with the EQ-
VAS is comparable to the EQ-5D with the EQ-VAS;
– Level sum score of the EQ-5D+C is differing from the 
level sum score on the EQ-5D in respondents with TBI 
or PTSD;
– Change in cognition is expected to be present in a larger 
percentage of respondents with TBI or PTSD than in 
respondents with neither TBI nor PTSD;
– The number of respondents with improved health in the 
Paretian Classification of Health is expected to increase 
with the addition of a cognitive domain in the group of 
TBI respondents, whereas the number of respondents 
with mixed change is expected to increase in the PTSD 
group.
Results
Research population
In total, 3941 respondents that presented to one of the hos-
pitals included in the LIS filled out at least one question-
naire. Out of these 3941 respondents, 1799 completed the 
EQ-5D+C and the EQ-VAS at both 6 and 12 months after 
trauma. The socio-demographics of responders and non-
responders are reported in Table 1. Within the group of 
responders, 273 respondents (15.2%) were diagnosed with 
TBI, and 107 (5.9%) reported PTSD, of which 18 respond-
ents reported both TBI and PTSD. Comparing responders 
to non-responders, there were significant differences in age, 
education level, number of chronic conditions, hospitalisa-
tion and presence of PTSD (p < 0.05).
Distributional effects
Figure 1 provides an overview of the percentage of respond-
ents that reported problems per domain at 6-month meas-
urement, for subgroups of patients with TBI, patients with 
PTSD and patients with neither TBI nor PTSD. Respondents 
with PTSD had the highest percentage of reported problems 
and mean level score on all domains.
For the EQ-5D, 473 out of 1799 respondents (26.3%) 
reported full health (no problems on any domain) 6 months 
after trauma, versus 434 out of 1799 (24.1%) on the EQ-
5D+C. Looking at the subgroups, full health was found 
on the EQ-5D for 99 out of 273 (36.3%) TBI patients, ver-
sus 79 out of 273 (28.9%) for EQ-5D+C. In the group of 
patients with PTSD one out of 107 (0.9%) patients reported 
full health for both EQ-5D and EQ-5D+C. Consider-
ing patients with neither TBI nor PTSD, 295 out of 1254 
(23.5%) patients for EQ-5D versus 278 out of 1254 (22.2%) 
for EQ-5D+C reported full health.
Classification efficiency: Shannon indices
In total, 308 out of 3125 (9.9%) health profiles were 
reported for EQ-5D, and 460 out of 15,625 (2.9%) for EQ-
5D+C. Comparing the diversity of the different subgroups 
(respondents with TBI, PTSD, and respondents with neither 
TBI nor PTSD), taking sample size into account, we found 
that respondents with PTSD showed the highest Shannon 
indices (H′ = 6.32 and J′ = 0.54 for EQ-5D and H′ = 6.60 
and J′ = 0.47 for EQ-5D+C), indicating that the group of 
respondents with PTSD was more heterogeneous in terms 
of health profiles (Table 2). For each subgroup, the Shannon 
Evenness Index was higher for the EQ-5D than for the EQ-
5D+C, indicating that more true information is captured. 
However, after adjusting for underestimation bias, the Shan-
non Evenness Index was higher for the EQ-5D+C than for 
the EQ-5D. This indicates that more information is captured 
in the EQ-5D+C.
Convergent validity
Convergent validity was higher for EQ-5D+C with EQ-VAS 
than for EQ-5D with EQ-VAS for all comparison groups 
(see Table 3). A negative relation was found as the level 
sum score decreases with better health while the EQ-VAS 
increases with better health. The convergent validity for the 
group of respondents with PTSD is much lower compared 
to the other subgroups.
Explanatory power
Generally, 41% of the variance of the EQ-VAS could be 
explained in TBI and PTSD patients by 5 domains of the 
EQ-5D+C (Table 4). For respondents with neither TBI nor 
PTSD 40% of the variance could be explained. The percent-
age of explained variance increased slightly with the addi-
tion of the cognitive domain for both groups. Explained vari-
ance was highest for the group with neither TBI nor PTSD 
when all six domains were included, whereas it was highest 
Quality of Life Research 
1 3
for the TBI/PTSD group with the domains mobility, self-
care, usual activities, pain/discomfort and cognition.
Discriminatory power
Mean level sum scores of EQ-5D and EQ-5D+C (adjusted 
for extra domain by multiplying with 5/6) were found to 
differ significantly (p < 0.05) for all groups, except for TBI 
patients (p = 0.211) (Table 5). Comparing level sum scores 
of the EQ-5D between respondents with TBI, respondents 
with PTSD and respondents with neither TBI nor PTSD, 
it was also found that scores differ significantly. The same 
applies to a comparison between groups of patients with no, 
one, and two or more chronic conditions.
Responsiveness to change
Table 6 provides an overview of the percentage of respond-
ents per subgroup (TBI, PTSD, neither TBI nor PTSD) 
per change category for each domain. For all domains, the 
Table 1  Demographics of 
responders and non-responders 
to the EQ-5D+C and EQ-VAS 
at 6 and 12 months after trauma
SD standard deviation, PTSD post-traumatic stress disorder, TBI traumatic brain injury
* Significant at a 5% level (p < 0.05)
a EQ-5D (+ C) measured at 6 months post-trauma
b Level sum score was used, not utility
Demographics of research population Responders Non-responders p value
n 1799 2142
Mean age (SD) 56.8 (23.2) 48.7 (29.3)  < 0.001*
Females 981 (54.5%) 1161 (54.2%) 0.837
Education level n (%)  < 0.001*
  Low education 713 (39.6%) 825 (38.5%)
  Middle education 380 (21.1%) 347 (16.2%)
  High education 411 (22.8%) 338 (15.8%)
  Missing 295 (16.4%) 632 (29.5%)
Chronic conditions n (%) 0.001*
  0 1031 (57.3%) 1316 (61.4%)
  1 461 (25.6%) 460 (21.5%)
   ≥ 2 269 (15.0%) 274 (12.8%)
  Missing 38 (2.1%) 92 (4.3%)
Hospitalisation n (%) 923 (51.3%) 958 (44.7%)  < 0.001*
PTSD n (%) 107 (5.9%) 110 (5.1%)  < 0.001*
Missing 212 (11.8%) 527 (24.6%)
TBI n (%) 273 (15.2%) 305 (14.2%) 0.408
EQ-5D-5L (+ C) scoresa
 Mobility (n (%) with problems) 789 (43.9%)
 Self-care (n (%) with problems) 374 (20.8%)
 Usual activities (n (%) with problems) 936 (52.0%)
 Pain/Discomfort (n (%) with problems) 1176 (65.4%)
 Anxiety/Depression (n (%) with problems) 460 (25.6%)
 Cognition (n (%) with problems) 472 (26.2%)
 EQ-VAS (SD) 74.8 (18.47)
 Level sum score EQ-5D (SD)b 8.4 (3.56)
 Level sum score EQ-5D+C (SD)b 9.8 (3.94)
 Health profile 11111 (n (%)) 473 (26.3%)
 Health profile 111111 (n (%)) 434 (24.1%)
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majority of patients (> 50%) showed no change. One excep-
tion is the group of respondents with PTSD, which shows a 
percentage below 50% with no change on both usual activi-
ties (36.4%) and anxiety/depression (49.5%). Furthermore, 
respondents with PTSD had, compared to the other sub-
groups, most often a change of one level over time (either 
positive or negative).
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
TBI PTSD None TBI PTSD None TBI PTSD None TBI PTSD None TBI PTSD None TBI PTSD None
Mobility Self-care Usual acvies Pain/discomfort Anxiety/depression Cognion
Extreme problems
Severe problems
Moderate problems
Slight problems
No problems
1.5 2.4       1.8       1.2       1.9      1.3       1.8       3.0      1.9       1.9       2.9       2.0      1.4       2.4  1.3       1.6      2.0       1.3
Fig. 1  Percentage of respondents per level per domain for subgroups of TBI, PTSD and neither, including mean level scores per subgroup per 
domain. NOTE: Responders can be represented in two categories: TBI and PTSD
Table 2  Shannon Index (H′) and Shannon Evenness Index (J′) of 
EQ-5D and EQ-5D+C 6 months after trauma
a Adjusted for underestimation bias
b None = No TBI and no PTSD
Health profile H′ Adjusteda H′ J′ Adjusteda J′
All EQ-5D 5.74 6.61 0.49 0.57
EQ-5D+C 6.37 10.71 0.46 0.77
TBI EQ-5D 4.60 10.32 0.40 0.45
EQ-5D+C 5.27 33.89 0.38 2.43
PTSD EQ-5D 6.32 20.92 0.54 1.80
EQ-5D+C 6.60 79.61 0.47 5.72
Noneb EQ-5D 5.62 6.86 0.48 0.59
EQ-5D+C 6.16 12.39 0.44 0.89
Table 3  Spearman’s Rank Correlation for level sum score EQ-5D 
with EQ-VAS and level sum score EQ-5D+C with EQ-VAS at 
6-month measurement for subgroups of TBI, PTSD and neither
a None = No TBI and no PTSD, CI 95% confidence interval
Group Variables Spearman’s Rank Correlation [CI]
All EQ-5D+EQ-VAS − 0.651 [− 0.679, − 0.620]
EQ-5D+C+EQ-VAS − 0.664 [− 0.693, − 0.634]
TBI EQ-5D+EQ-VAS − 0.628 [− 0.701, − 0.541]
EQ-5D+C+EQ-VAS − 0.640 [− 0.717, − 0.556]
PTSD EQ-5D+EQ-VAS − 0.471 [− 0.622, − 0.283]
EQ-5D+C+EQ-VAS − 0.491 [− 0.639, − 0.302]
Nonea EQ-5D+EQ-VAS − 0.616 [− 0.653, − 0.577]
EQ-5D+C+EQ-VAS − 0.630 [− 0.667, − 0.592]
Table 4  Explanatory power of multivariable models for EQ-VAS 
with any combination of five of the EQ-5D+C domains for TBI/
PTSD and neither TBI nor PTSD respondents
MO mobility, SC self-care, UA usual activities, PD pain/discomfort, 
AD anxiety/depression, CO cognition
a No TBI and no PTSD
* Significant at a 5% level (p < 0.05)
Group Variables R2 adjusted F value p value
TBI/PTSD MO, SC, UA, PD, AD 0.413 13.68  < 0.001*
MO, SC, UA, PD, AD, 
CO
0.415 11.66  < 0.001*
MO, UA, PD, AD, CO 0.416 13.85  < 0.001*
MO, SC, PD, AD, CO 0.393 12.67  < 0.001*
MO, SC, UA, AD, CO 0.402 13.15  < 0.001*
MO, SC, UA, PD, CO 0.418 13.98  < 0.001*
SC, UA, PD, AD, CO 0.411 13.61  < 0.001*
Nonea MO, SC, UA, PD, AD 0.401 42.97  < 0.001*
MO, SC, UA, PD, AD, 
CO
0.414 37.91  < 0.001*
MO, UA, PD, AD, CO 0.404 43.47  < 0.001*
MO, SC, PD, AD, CO 0.389 40.82  < 0.001*
MO, SC, UA, AD, CO 0.403 43.27  < 0.001*
MO, SC, UA, PD, CO 0.408 44.21  < 0.001*
SC, UA, PD, AD, CO 0.403 43.21  < 0.001*
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According to the Paretian classification of Health changes 
(see “Methods” section), we observed that approximately 
a third of respondents improved over time (Table 7, row 
’Improve’). The percentage of respondents that universally 
improved in all domains was slightly lower in the EQ-
5D-5L+C, while the percentage of respondents with mixed 
results in domains was a little higher. This indicates that 
while improvement or stability was found for the domains 
of the EQ-5D-5L, there was deterioration in the cognitive 
domain for some respondents (resulting in the mixed, non-
categorisable change group). Results in clinical subgroups 
based on TBI, PTSD and no PTSD or TBI were similar. 
Change in classification between EQ-5D and EQ-5D+C 
can be explained by a change in the cognitive domain in 
another direction than change on the other domains, which 
was clearly noted in the group of respondents with PTSD. 
Here, the mixed change response was 26.2% in EQ-5D vs. 
40.2% in EQ-5D+C. Furthermore, for TBI patients there 
was a 6.9% decrease in patients with no problems and a 
1.8% increase in the ‘improve’ category when the cognitive 
domain was included.
Domain wise, the probability of a positive change over 
time showed most improvement in usual activities and pain/
discomfort (58%) and least improvement in cognition (50%) 
(Table 8). Subgroup analysis showed similar results for usual 
activities and pain/discomfort; however, cognition was found 
to have a higher probability of superiority in respondents 
with TBI and respondents with PTSD than in respondents 
with neither TBI nor PTSD.
Table 5  Mean level sum score for EQ-5D and EQ-5D+C for two sub-
group classifications at 6-month measurement
a None = No TBI and no PTSD
*Significant at a 5% level (p < 0.05)
Group Level sum 
score EQ-5D
Level sum 
score EQ-
5D+C
p value
All 8.4 8.2  < 0.001*
TBI 7.8 7.8 0.211
PTSD 12.6 12.1  < 0.001*
Nonea 8.4 8.1  < 0.001*
p value  < 0.001*  < 0.001* –
No chronic condition 7.3 7.2  < 0.001*
1 chronic condition 9.4 9.1  < 0.001*
 ≥ 2 chronic conditions 10.9 10.4  < 0.001*
p value  < 0.001*  < 0.001* –
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Discussion
Main findings
This study investigated the potential gain of adding a cogni-
tive domain to the EQ-5D-5L and analysed the distributional 
effects, construct validity and responsiveness to change of 
the instrument in a group of trauma patients with measure-
ment of HRQL at 6 and 12 months after trauma. The addi-
tion of a cognitive domain slightly decreased the percentage 
of respondents reporting full health, which was in line with 
our first hypothesis. It also increased the adjusted Shannon 
Index and adjusted Shannon Evenness Index at both 6-month 
and 12-month measurement. Convergent validity and 
explanatory power of the EQ-5D with the EQ-VAS increased 
slightly with the addition of cognition, as expected. Further-
more, the level sum score of the EQ-5D and EQ-5D+C for 
subgroups based on TBI or PTSD presence and on num-
ber of chronic conditions differed significantly, which was 
in line with the third hypothesis, except for TBI patients. 
Results of the responsiveness to change analyses showed 
that change over time in the cognitive domain was, espe-
cially in respondents with PTSD, often in reverse direction 
of change in other domains. This can be explained by find-
ings of previous studies among trauma patients that showed 
that PTSD symptoms can exacerbate over time [27–29]. In 
TBI patients on the other hand, it was found that the percent-
age of respondents with improved health increased with the 
inclusion of the cognitive domain. This was in line with 
the fifth hypothesis, and can be explained by the expected 
improvement in cognition over time in TBI patients. Further-
more, only a small percentage of respondents with neither 
PTSD nor TBI showed change on the cognitive domain over 
time.
Comparison to previous studies
Previous studies on measurement properties of the EQ-
5D-5L did not investigate the cognitive domain, and 
focussed mainly on the comparison of the EQ-5D-5L with 
the EQ-5D-3L in a specific population, such as stroke 
patients, patients with psoriasis, cancer patients, and patients 
with hepatitis B [9–12, 30–32]. The studies by Poór et al. 
[30], Kim et al. [31] and Scalone et al. [32] found that ceil-
ing effects decreased in the EQ-5D-5L compared to the 
EQ-5D-3L. In our study, we found high ceiling effects, 
especially 12 months post-trauma, most likely due to the 
fact that the majority of our study sample sustained mild to 
moderate trauma and most patients had recovered fully over 
12 months. A previous study by Geraerds et al. [17] com-
pared ceiling effects of the EQ-5D-3L and EQ-5D-3L+C 
in a sample of trauma patients in the Brabant region of the 
Netherlands who were admitted to the hospital due to injury. 
Their results are in agreement with our findings on the ceil-
ing effects of the EQ-5D-5L and EQ-5D-5L+C, namely that 
fewer respondents reported perfect health when the EQ-
5D+C is used. Furthermore, both the studies by Geraerds 
et al. [17] and Ophuis et al. [18] concluded that adding a 
cognitive domain slightly increased the explanatory power 
of the EQ-5D-3L. This is in line with the findings in this 
study, for the EQ-5D-5L. Another study that looked into 
the effect of adding a domain to the EQ-5D is the study by 
Table 7  Health (EQ-5D, EQ-5D+C) profile change over time according to Paretian classification for profile changes, for all trauma patients and 
by subgroup
a None = No TBI and no PTSD
Paretian classification of health change All TBI PTSD Nonea
EQ-5D EQ-5D+C EQ-5D EQ-5D+C EQ-5D EQ-5D+C EQ-5D EQ-5D+C
No problems 22.1% 20.1% 32.2% 25.3% – – 19.3% 18.0%
No change (including no problems) 30.2% 27.0% 38.1% 31.2% 5.6% 3.7% 28.5% 25.9%
Improve 39.5% 38.2% 32.6% 34.4% 46.7% 38.3% 42.7% 41.1%
Worsen 16.5% 16.6% 15.0% 15.4% 21.5% 17.8% 16.3% 16.7%
Non-categorisable (mixed change) 13.8% 18.2% 14.3% 19.0% 26.2% 40.2% 12.5% 16.3%
Total n 1799 273 107 1254
Table 8  Probability of superiority per domain of the EQ-5D+C for 
study population
PoS probability of superiority
a None = No TBI and no PTSD
Domain PoS
All TBI PTSD Nonea
Mobility 0.55 0.53 0.54 0.56
Self-care 0.52 0.51 0.54 0.53
Usual activities 0.58 0.57 0.62 0.59
Pain/discomfort 0.58 0.56 0.60 0.59
Anxiety/depression 0.51 0.52 0.57 0.51
Cognition 0.50 0.52 0.52 0.50
Quality of Life Research 
1 3
Swinburn et al. [33], who analysed the effect of adding an 
extra domain to the EQ-5D-5L for psoriasis patients. The 
results of their study showed that additional variance was 
captured by adding two extra domains for this specific popu-
lation. This indicates that measurement of HRQL in specific 
patient populations might benefit from adding bolt-ons to the 
EQ-5D-3L as well as the EQ-5D-5L.
To our knowledge, responsiveness to change of the EQ-
5D-5L+C has not been studied before. One study that ana-
lysed the responsiveness of the EQ-5D-3L in patients that 
underwent surgery for a hernia repair, varicose vein surgery, 
or cataract surgery determined the Paretian classification 
as well [26]. Results showed that in the group of patients 
who underwent hernia repair and the group of patients that 
underwent varicose vein surgery, health status of the major-
ity improved. Relating these results to our own study is com-
plicated, as different variants of the EQ-5D were used and 
study population differed. However, the explorative results 
of our study showed the same change over time: for the 
majority of the research population health status improved 
over time (subgroup of respondents with PTSD excepted, 
where more mixed change was found).
Even though it is difficult to compare the findings of our 
study with previous findings, we believe that our findings 
add information to the discussion on whether or not the five 
domains of the EQ-5D-5L are sufficient to measure HRQL. 
Especially in patients with diagnoses that are associated with 
cognitive impairments, such as TBI patients and patients 
with PTSD, the EQ-5D-5L+C outperformed the EQ-5D-5L; 
even though improvements were rather small. In addition, 
the findings of our study showed that in a specific popula-
tion, replacing one of the EQ-5D domains with a bolt-on 
domain may increase the explanatory power. This could be 
due to domain dependency, which could be studied further 
in future research.
Strengths and limitations
This study had strengths and limitations that need to be 
taken into account when interpreting the results. One of the 
strengths of our study was to have access to a large, longitu-
dinal dataset of trauma patients. A second strength was that 
information on the presence of TBI and PTSD was avail-
able. Finally, the multi-criteria psychometric strategy that 
was adopted proved to be a useful approach to assess the 
benefit of adding the cognitive domain to EQ-5D.
An important limitation of our study was that the sever-
ity level of trauma appears to be low in the study popula-
tion. Due to the absence of information on severity level of 
trauma of the respondents this suspicion cannot be supported 
with data. However, results showed that, compared to previ-
ous research, large ceiling effects were found, which could 
indicate that the severity of trauma of our research popula-
tion was rather mild. Therefore, the study population might 
not be representative for a general trauma population.
Another limitation of our study was that the number of 
respondents with PTSD was low (107 (5.9%)). This may be 
the result of sampling bias, meaning that respondents with 
PTSD had a lower probability of participating in the study. 
A study by Geraerds et al. [34] studied a similar popula-
tion of trauma patients in the Netherlands and found that 
responders were more severely injured than non-responders. 
In this study, we found that there were no respondents with 
PTSD that reported no problems, and that the percentage of 
respondents with positive change was highest for the PTSD 
group, compared to the TBI group and the group with nei-
ther TBI nor PTSD. This could indicate that only respond-
ents with PTSD who suffered severe injuries participated in 
our study. Therefore, results with respect to PTSD should 
be interpreted with caution, as the PTSD population might 
not be representative. Possible outliers in the PTSD group 
will have had a large effect on the outcomes, and could have 
affected the results.
Conclusion
In conclusion, adding a cognitive domain to the EQ-5D-5L 
decreased ceiling effects and improved the classification 
efficiency and the responsiveness of the EQ-5D-5L. Even 
though improvements in measurement properties were 
small, the results of a responsiveness analysis indicate that a 
cognitive domain is relevant, especially in respondents with 
TBI and/or PTSD, as a higher percentage of these respond-
ents showed change on the cognitive domain. Cognition 
of respondents with TBI and/or PTSD changed between 6 
and 12 months post-trauma for a larger percentage of the 
group than for the group of respondents with neither TBI 
nor PTSD. Since TBI and PTSD are both associated with 
cognitive problems, this underlines the relevance of add-
ing the cognition bolt-on to the EQ-5D-5L when measuring 
HRQL in a population with cognitive problems.
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